Conditions: Rhinitis
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 61
Healthy volunteers: no

Brief summary:
Safety of GW685698X (55 µg/day, q.d.) nasal spray over a period of 12 weeks in Japanese paediatric subjects ages 2 to \< 15 years with perennial allergic rhinitis will be evaluated. And secondarily, efficacy and systemic exposure of GW685698X (55 µg/day, q.d.) nasal spray over a period of 12 weeks in Japanese paediatric subjects ages 2 to \< 15 years with perennial allergic rhinitis will also be evaluated.

Detailed description:

Arms:
arm 1: GW685698X 55mcg/day

Interventions: intervention 1: Fluticasone furoate
Intervention descriptions: intervention 1: 55 mcg/day, intranasal, 12 weeks

Protocol document: